According to a recent LinkedIn post from Lyfegen, the company plans to participate in the PPIC 2026 (Pharma Pricing & Access Innovation Conference) and HPEF 2026 (Healthcare Payer Exchange Forum) events in Basel from June 9–12, hosted by partner EVERSANA. The post notes that pharma and payer leaders are expected to attend at a time when MFN, JCA, and AI-driven decision making are influencing approaches to pricing, access, and contracting.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The post suggests that Lyfegen is positioning itself within key industry discussions on drug pricing, market access, and value-based contracting, alongside a major commercialization partner. For investors, this visibility at a specialized pricing and payer forum may indicate ongoing efforts to deepen relationships with payers and pharma clients, potentially supporting future commercial opportunities and reinforcing its role in AI-enabled health tech and market access solutions.